Andersons pediatric cardiology 2292

DC,etal.Screeningforlipiddisordersin
childrenandadolescents:USpreventiveservices
taskforcerecommendationstatement.JAMA.
2016;316(6):625–633.
110.deJonghS,LilienMR,op'tRoodtJ,etal.Early
statintherapyrestoresendothelialfunctionin
childrenwithfamilialhypercholesterolemia.J
AmCollCardiol.2002;40(12):2117–2121.
111.WiegmanA,HuttenBA,deGrootE,etal.
Efficacyandsafetyofstatintherapyinchildren
withfamilialhypercholesterolemia:a
randomizedcontrolledtrial.JAMA.
2004;292(3):331–337.
112.McCrindleBW,KwiterovichPO,McBridePE,
DanielsSR,KaveyRE.Guidelinesforlipid
screeninginchildrenandadolescents:bringing
evidencetothedebate.Pediatrics.
2012;130(2):353–356.
113.RodenburgJ,VissersMN,WiegmanA,etal.
Statintreatmentinchildrenwithfamilial
hypercholesterolemia:theyounger,thebetter.
Circulation.2007;116(6):664–668.
114.AvisHJ,VissersMN,SteinEA,etal.A
systematicreviewandmeta-analysisofstatin
therapyinchildrenwithfamilial
hypercholesterolemia.ArteriosclerThrombVasc
Biol.2007;27(8):1803–1810.


115.ObarzanekE,HunsbergerSA,VanHornL,etal.
Safetyofafat-reduceddiet:thedietary

interventionstudyinchildren(DISC).
Pediatrics.1997;100(1):51–59.
116.RobertsWC.Thecongenitallybicuspidaortic
valve.Astudyof85autopsycases.AmJ
Cardiol.1970;26(1):72–83.
117.WardC.Clinicalsignificanceofthebicuspid
aorticvalve.Heart.2000;83(1):81–85.
118.SteinbergerJ,MollerJH,BerryJM,SinaikoAR.
Echocardiographicdiagnosisofheartdiseasein
apparentlyhealthyadolescents.Pediatrics.
2000;105(4Pt1):815–818.
119.FedakPW,VermaS,DavidTE,etal.Clinical
andpathophysiologicalimplicationsofa
bicuspidaorticvalve.Circulation.
2002;106(8):900–904.
120.CripeL,AndelfingerG,MartinLJ,ShoonerK,
BensonDW.Bicuspidaorticvalveisheritable.J
AmCollCardiol.2004;44(1):138–143.
121.SiuSC,SilversidesCK.Bicuspidaorticvalve
disease.JAmCollCardiol.2010;55(25):2789–
2800.
122.BravermanAC.Aorticinvolvementinpatients
withabicuspidaorticvalve.Heart.
2011;97(6):506–513.
123.VermaS,SiuSC.Aorticdilatationinpatients


withbicuspidaorticvalve.NEnglJMed.
2014;370(20):1920–1929.
124.BravermanAC,HarrisKM,KovacsRJ,Maron

BJ.Eligibilityanddisqualification
recommendationsforcompetitiveathleteswith
cardiovascularabnormalities:taskforce7:aortic
diseases,Includingmarfansyndrome:a
scientificstatementfromtheAmericanheart
associationandAmericancollegeofcardiology.
JAmCollCardiol.2015;66(21):2398–2405.
125.MichelenaHI,KhannaAD,MahoneyD,etal.
Incidenceofaorticcomplicationsinpatients
withbicuspidaorticvalves.JAMA.
2011;306(10):1104–1112.
126.HiratzkaLF,BakrisGL,BeckmanJA,etal.2010
ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM
guidelinesforthediagnosisandmanagementof
patientswiththoracicaorticdisease.Areportof
theAmericancollegeofcardiology
Foundation/Americanheartassociationtask
forceonpracticeguidelines,American
associationforthoracicsurgery,American
collegeofradiology,Americanstroke
association,Societyofcardiovascular
anesthesiologists,Societyforcardiovascular
angiographyandinterventions,Societyof
interventionalradiology,Societyofthoracic